Literature DB >> 22453922

Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability.

Petra Baresova1, Paula M Pitha, Barbora Lubyova.   

Abstract

The Kaposi sarcoma-associated herpesvirus (KSHV) has been linked to Kaposi sarcoma, body cavity-based lymphoma, and Castleman disease. vIRF-3 is a KSHV latent gene that is critical for proliferation of KSHV-positive lymphoid cells. Furthermore, vIRF-3 contributes to KSHV-associated pathogenesis by stimulating c-Myc transcription activity. Here we show that vIRF-3 can associate with Skp2, a key component of the SCF(skp2) ubiquitin ligase complex. Skp2 is a transcriptional co-factor for c-Myc that was shown to regulate the stability of c-Myc protein as well as c-Myc-dependent transcription. In this study, we show that vIRF-3 binds to the F-box of Skp2 and recruits it to c-Myc-regulated promoters to activate c-Myc-dependent transcription. Additionally, cells overexpressing vIRF-3 exhibit higher levels of c-Myc ubiquitylation, suggesting that ubiquitylation is necessary for c-Myc-mediated transcription. Moreover, vIRF-3 can stabilize the c-Myc protein by increasing its half-life. Collectively, these results indicate that vIRF-3 can effectively manipulate c-Myc stability and function and thus contribute to c-Myc-induced KSHV-associated lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453922      PMCID: PMC3351320          DOI: 10.1074/jbc.M111.335216

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.

Authors:  B Lüscher; L G Larsson
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

2.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.

Authors:  Neetu Kalra; Vijay Kumar
Journal:  FEBS Lett       Date:  2005-12-20       Impact factor: 4.124

Review 4.  The pleiotropic effects of Kaposi's sarcoma herpesvirus.

Authors:  Thomas F Schulz
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

5.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

Authors:  N Dupin; T L Diss; P Kellam; M Tulliez; M Q Du; D Sicard; R A Weiss; P G Isaacson; C Boshoff
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 6.  AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation.

Authors:  G Gaidano; C Pastore; A Gloghini; G Volpe; P Ghia; G Saglio; A Carbone
Journal:  Acta Haematol       Date:  1996       Impact factor: 2.195

7.  Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.

Authors:  D Bubman; I Guasparri; E Cesarman
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

8.  Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis.

Authors:  Ulrich B Keller; Jennifer B Old; Frank C Dorsey; Jonas A Nilsson; Lisa Nilsson; Kirsteen H MacLean; Linda Chung; Chunying Yang; Charles Spruck; Kelli Boyd; Steven I Reed; John L Cleveland
Journal:  EMBO J       Date:  2007-04-26       Impact factor: 11.598

9.  Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.

Authors:  Chul Hyun Joo; Young C Shin; Michaela Gack; Liguo Wu; David Levy; Jae U Jung
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.

Authors:  Jianyong Liu; Heather J Martin; Gangling Liao; S Diane Hayward
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

View more
  15 in total

1.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.

Authors:  Hye-Ra Lee; Sultan Doğanay; Brian Chung; Zsolt Toth; Kevin Brulois; Stacy Lee; Zhansaya Kanketayeva; Pinghui Feng; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance.

Authors:  Liansheng Qiu; Jiabao Lv; Yimin Chen; Jiarong Wang; Ruishan Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

4.  Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7.

Authors:  Hyun Jin Kwun; Masahiro Shuda; Huichen Feng; Carlos J Camacho; Patrick S Moore; Yuan Chang
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

5.  Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.

Authors:  S Lee; W Kim; C Ko; W-S Ryu
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

6.  The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3.

Authors:  Sarah R Jacobs; Sean M Gregory; John A West; Amy C Wollish; Christopher L Bennett; David J Blackbourn; Mark T Heise; Blossom Damania
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

7.  Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.

Authors:  Haidai Hu; Jiazhen Dong; Deguang Liang; Zengqiang Gao; Lei Bai; Rui Sun; Hao Hu; Heng Zhang; Yuhui Dong; Ke Lan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

8.  Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs.

Authors:  Angela Park; Soohwan Oh; Kyle L Jung; Un Yung Choi; Hye-Ra Lee; Michael G Rosenfeld; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

9.  p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3.

Authors:  Petra Baresova; Jana Musilova; Paula M Pitha; Barbora Lubyova
Journal:  Mol Cell Biol       Date:  2013-11-18       Impact factor: 4.272

Review 10.  Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer.

Authors:  Petra Baresova; Paula M Pitha; Barbora Lubyova
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.